| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 64.7% | 11/17 |
| Female | 35.3% | 6/17 |
| Indifferent | 0% | 0/17 |
| Unknown | 0% | 0/17 |
| General | ||
| Birth Length | 0% | 0/17 |
| 5.9% | 1/17 | |
| Birth Head circumference | 0% | 0/17 |
| 41.2% | 7/17 | |
| 23.5% | 4/17 | |
| 47.1% | 8/17 | |
| 70.6% | 12/17 | |
| 88.2% | 15/17 | |
| 52.9% | 9/17 | |
| 80% | 8/10 | |
| Neurology | ||
| 29.4% | 5/17 | |
| 76.5% | 13/17 | |
| 35.3% | 6/17 | |
| Facial abnormalities | ||
| 23.5% | 4/17 | |
| 41.2% | 7/17 | |
| 29.4% | 5/17 | |
| 35.3% | 6/17 | |
| Visual and hearing impairments | ||
| Abnormal hearing | 0% | 0/17 |
| 23.5% | 4/17 | |
| Heart | ||
| Abnormality of the heart | 0% | 0/17 |
| Pulmonary | ||
| 5.9% | 1/17 | |
| Gastrointestinal | ||
| 17.6% | 3/17 | |
| Urogenital | ||
| Urogenital | 0% | 0/17 |
| Skeleton | ||
| 47.1% | 8/17 | |
| Skin / Hair / Nails | ||
| 5.9% | 1/17 | |
| Endocrine / Immunological / Metabolic | ||
| 5.9% | 1/17 | |
| 11.8% | 2/17 | |
| Immune | 0% | 0/17 |
| Neoplasia | ||
| Neoplasia | 5.9% | 1/17 |
| Inheritance | ||
| 100% | 17/17 | |
WDFY3